Test Research, Inc.

TWSE:3030 Voorraadrapport

Marktkapitalisatie: NT$31.3b

Test Research Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Test Research.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Electronic winstgroei22.1%
Inkomstengroein/a
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

None

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Oct 17
Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Aug 05
Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Jul 11
Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Jun 01
Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

May 31
Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Apr 15
Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

Mar 19
Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Mar 01
With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Should You Invest In Test Research (TPE:3030)?

Feb 11
Should You Invest In Test Research (TPE:3030)?

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Jan 24
Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 05
Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Dec 18
Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Nov 30
Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Test Research onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

TWSE:3030 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (TWD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/20245,5701,4469541,375N/A
3/31/20244,7791,1869631,473N/A
12/31/20234,4351,0011,0011,878N/A
9/30/20234,5401,0431,0812,020N/A
6/30/20235,0511,2831,2072,278N/A
3/31/20235,9551,6021,2562,294N/A
12/31/20226,7091,9217871,467N/A
9/30/20226,6201,855342967N/A
6/30/20226,4671,657-13308N/A
3/31/20226,1801,48029274N/A
12/31/20215,6071,185436591N/A
9/30/20215,2281,0719111,008N/A
6/30/20215,2021,0931,1151,192N/A
3/31/20215,1361,1181,1441,205N/A
12/31/20204,9511,0931,0681,120N/A
9/30/20205,1561,157830874N/A
6/30/20204,8401,0611,0721,122N/A
3/31/20204,5739701,0311,083N/A
12/31/20194,3879391,3041,358N/A
9/30/20194,2619391,5451,600N/A
6/30/20194,4669611,2921,341N/A
3/31/20194,8311,088948998N/A
12/31/20184,9191,064576627N/A
9/30/20184,752976-50-5N/A
6/30/20184,616987-137-91N/A
3/31/20183,915734N/A109N/A
12/31/20173,601595N/A248N/A
9/30/20173,397552N/A588N/A
6/30/20173,017370N/A345N/A
3/31/20173,131400N/A551N/A
12/31/20163,100429N/A553N/A
9/30/20163,155389N/A658N/A
6/30/20164,012752N/A805N/A
3/31/20164,322821N/A681N/A
12/31/20154,754999N/A676N/A
9/30/20154,9611,152N/A974N/A
6/30/20156,4741,497N/A1,641N/A
3/31/20156,3741,452N/A1,519N/A
12/31/20145,8701,260N/A1,155N/A
9/30/20145,8511,207N/A1,029N/A
6/30/20144,375830N/A759N/A
3/31/20144,076796N/A768N/A
12/31/20134,084806N/A1,115N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if 3030's forecast earnings growth is above the savings rate (1%).

Winst versus markt: Insufficient data to determine if 3030's earnings are forecast to grow faster than the TW market

Hoge groeiwinsten: Insufficient data to determine if 3030's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if 3030's revenue is forecast to grow faster than the TW market.

Hoge groei-inkomsten: Insufficient data to determine if 3030's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if 3030's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y